Balance Sheet
Liabilities and Shareholders Equity
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Short-term Investments (2019 - 2024)

KalVista Pharmaceuticals' Short-term Investments history spans 5 years, with the latest figure at $86.0 million for Q4 2024.

  • For Q4 2024, Short-term Investments changed N/A year-over-year to $86.0 million; the TTM value through Dec 2024 reached $86.0 million, changed N/A, while the annual FY2024 figure was $178.6 million, N/A changed from the prior year.
  • Short-term Investments for Q4 2024 was $86.0 million at KalVista Pharmaceuticals, down from $94.2 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $178.6 million in Q2 2024 and bottomed at $32.6 million in Q1 2021.
  • The 4-year median for Short-term Investments is $57.2 million (2020), against an average of $75.5 million.
  • The largest annual shift saw Short-term Investments tumbled 47.41% in 2021 before it soared 106.99% in 2024.
  • A 4-year view of Short-term Investments shows it stood at $39.7 million in 2020, then fell by 17.92% to $32.6 million in 2021, then skyrocketed by 39.66% to $45.5 million in 2023, then skyrocketed by 89.03% to $86.0 million in 2024.
  • Per Business Quant, the three most recent readings for KALV's Short-term Investments are $86.0 million (Q4 2024), $94.2 million (Q4 2024), and $142.4 million (Q3 2024).